Latest Natalizumab Stories
EXTON, Pa., Nov. 2, 2010 /PRNewswire/ -- BioTrends Research Group, Inc. has released a syndicated report focused on the management and treatment of multiple sclerosis (MS) in the US.
ATLANTA, Oct. 15 /PRNewswire/ -- Studies and analyses of the Crohn's disease (CD) treatment CimziaÂ® (certolizumab pegol) will be exhibited at the 2010 Annual Scientific Meeting of the American College of Gastroenterology, taking place in San Antonio from October 15 - 20.
BURLINGTON, Mass., Sept.
PLYMOUTH, Minn., June 29 /PRNewswire/ -- Midwest Infusion Center expanded from its previous space at West Health by opening a new infusion center at the City Center Professional Building in Plymouth for patients receiving infusion therapy. Midwest Infusion Center is a unique treatment center designed for patients to receive complex therapies in a safe, comfortable and non-clinical setting.
ATLANTA, June 16 /PRNewswire-FirstCall/ -- UCB today announced new CimziaÂ® (certolizumab pegol) data demonstrating rapid and sustained improvements in managing moderate to severe rheumatoid arthritis (RA) symptoms and pain for patients, as well as results of a survey showing the impact of RA pain on the daily lives of women, focusing on productivity and relationships, during the 2010 European League Against Rheumatism (EULAR) annual congress in Rome, Italy, June 16-19. "Insights from these...
Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN), in collaboration with EPI-Q, Inc. and Avatar International, LLC, today announced the launch of My MS Health, a first-of-its-kind, web-based, patient-reported outcomes (PRO) research program.
ATLANTA, May 2 /PRNewswire/ -- UCB announced today results of an open-label extension study, PRECiSE 4 (P4), of CimziaÂ® (certolizumab pegol; CZP) demonstrating that Cimzia provides sustained efficacy over four years in moderate to severe Crohn's Disease patients regardless of whether patients were previously treated with infliximab (IFX) or infliximab-naive.
ATLANTA, April 29 /PRNewswire/ -- Studies and analyses of the Crohn's Disease (CD) treatment CimziaÂ® (certolizumab pegol) demonstrating new data will be exhibited at Digestive Disease Week (DDW) 2010, taking place in New Orleans from May 1-5, 2010. "Cimzia data at this year's DDW provide important and positive clinical insights, namely, that Cimzia offers long-term efficacy in multiple patient populations," said Cem Kayhan, MD, Associate Medical Director at UCB.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.